Indian high-tech company, ReproSci Biosciences, sets up facility in BioVille

This spring, India-based high-tech company ReproSci Biosciences will open a facility at the new Health Campus in Diepenbeek, specifically in BioVille. This will be the company’s first expansion outside Asia, which specializes in fertility and reproductive health care.

ReproSci Biosciences is a relatively young company based in Bangalore – India’s third-largest city. The company operates within the realm of “femtech,” an emerging healthcare sector focused on women-centric solutions. According to projections, that sector will be worth some 55 billion euros in six years, with an annual growth rate of more than 16 percent. Among other things, ReproSci developed the Fertilator, a virtual reality simulator focused on egg retrieval.

ReproSci had had expansion plans for Europe for some time, and is now explicitly choosing BioVille and the new Health Campus in Diepenbeek. This is mainly due to the efforts of Flemish export and investment agency Flanders Investment and Trade (FIT) India and POM Limburg.

Vijaygopal Rengarajan, CEO of Reprosci, said, “We are happy to be part of the dynamic ecosystem of Health Campus Limburg DC. This collaboration with the university and nearby hospitals allows us to advance technological advances in medical education through simulation-based training. Together, we aim to revolutionize medical training so that healthcare professionals can be better prepared and achieve better outcomes. This is an important milestone in ReproSci’s growth and innovation journey, especially for our flagship product, the Fertilator, and beyond.”

Ecosystem
The arrival of ReproSci fits perfectly into the ecosystem that POM Limburg is building on the Health Campus. Commissioner for Economy and Chairman of POM Limburg Tom Vandeput, states, “This is another promising start-up that finds its way to Diepenbeek. The innovative environment of the campus and its growing ecosystem, play a crucial role in this decision.”